Novo Nordisk India Profile
Key Indicators
- Authorised Capital ₹ 33.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 26.50 Cr
as on 23-10-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 133.50 Cr
as on 23-10-2024
- Revenue 16.40%
(FY 2023)
- Profit 44.35%
(FY 2023)
- Ebitda 48.78%
(FY 2023)
- Net Worth 24.18%
(FY 2023)
- Total Assets 29.28%
(FY 2023)
About Novo Nordisk India
The Corporate was formerly known as Novo Nordisk Pharma India Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 33.00 Cr and a paid-up capital of Rs 26.50 Cr.
The company has closed loans amounting to ₹133.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novo Nordisk India Private Limited India is Juhi Pant as COMPANY SECRETARY. Vikrant Shrotriya, Sebnem Tuna, Kasper Poulsen, and One other member serve as directors at the Company.
- CIN/LLPIN
U24111KA1994PTC015194
- Company No.
015194
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 1994
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Novo Nordisk India Private Limited offer?
Novo Nordisk India Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Healthcare Devices, Diabetes Monitors, Devices, Syringes & Pens.
Who are the key members and board of directors at Novo Nordisk India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Juhi Pant | Company Secretary | 03-Apr-2024 | Current |
Vikrant Shrotriya  | Managing Director | 03-Jan-2020 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sebnem Tuna  | Director | 27-Aug-2020 | Current |
Kasper Poulsen  | Director | 27-Aug-2020 | Current |
| Amit Das | Whole-Time Director | Current |
Financial Performance of Novo Nordisk India.
Novo Nordisk India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.4% increase. The company also saw a substantial improvement in profitability, with a 44.35% increase in profit. The company's net worth Soared by an impressive increase of 24.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Nordisk India?
In 2023, Novo Nordisk India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novo Nordisk Service Centre (India) Private LimitedActive 13 years 11 monthsVikrant Shrotriya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 24 Mar 2003 | ₹50.00 Cr | Satisfied |
Citi Bank N.A. Creation Date: 24 Mar 2003 | ₹50.00 Cr | Satisfied |
Citi Bank N.A. Creation Date: 07 Sep 1998 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Novo Nordisk India?
Novo Nordisk India has a workforce of 1533 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Nordisk India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Nordisk India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
